Humasis Co. Ltd Market Cap ($172.92 Million)
Market Cap & Net Worth: Humasis Co. Ltd (205470)
Humasis Co. Ltd market cap. Humasis Co. Ltd (KQ:205470) has a market capitalization of $172.92 Million (₩255.16 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #16906 globally and #646 in its home market, demonstrating a -4.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Humasis Co. Ltd's stock price ₩2255.00 by its total outstanding shares 113153840 (113.15 Million). Also see Humasis Co. Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Humasis Co. Ltd Market Cap History (2015–2026)
Humasis Co. Ltd market cap history from 2015 to 2026. Data shows growth from $37.79 Million to $172.92 Million (14.18% CAGR). Check 205470 stock price and chart for real-time trading data and today's change.
Index Memberships
Humasis Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.08% | #225 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.08% | #225 of 1384 |
Weight: Humasis Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Humasis Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Humasis Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Humasis Co. Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Humasis Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $39.66 Million | $8.51 Billion | -$4.72 Billion | 0.00x | N/A |
| 2018 | $25.54 Million | $9.66 Billion | -$852.81 Million | 0.00x | N/A |
| 2019 | $26.01 Million | $9.15 Billion | -$1.23 Billion | 0.00x | N/A |
| 2020 | $177.74 Million | $45.72 Billion | $21.08 Billion | 0.00x | 0.01x |
| 2021 | $316.28 Million | $321.83 Billion | $151.20 Billion | 0.00x | 0.00x |
| 2022 | $273.18 Million | $471.27 Billion | $182.63 Billion | 0.00x | 0.00x |
| 2023 | $144.62 Million | $13.83 Billion | -$55.42 Billion | 0.01x | N/A |
| 2024 | $125.53 Million | $25.41 Billion | -$30.44 Billion | 0.00x | N/A |
Competitor Companies of 205470 by Market Capitalization
Companies near Humasis Co. Ltd in the global market cap rankings as of November 4, 2026. Also see balance sheet size of Humasis Co. Ltd for a full breakdown of the balance sheet.
Key companies related to Humasis Co. Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Humasis Co. Ltd (2015–2026)
Market capitalization of Humasis Co. Ltd from 2015 to today. Between 2015 and today, Humasis Co. Ltd's market cap moved from $37.79 Million to $ 172.92 Million, with a yearly change of 14.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩172.92 Million | +122.39% |
| 2025 | ₩77.76 Million | -38.06% |
| 2024 | ₩125.53 Million | -13.20% |
| 2023 | ₩144.62 Million | -47.06% |
| 2022 | ₩273.18 Million | -13.63% |
| 2021 | ₩316.28 Million | +77.95% |
| 2020 | ₩177.74 Million | +583.45% |
| 2019 | ₩26.01 Million | +1.83% |
| 2018 | ₩25.54 Million | -35.61% |
| 2017 | ₩39.66 Million | +5.47% |
| 2016 | ₩37.61 Million | -0.50% |
| 2015 | ₩37.79 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Humasis Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $172.92 Million USD |
| MoneyControl | $172.92 Million USD |
| MarketWatch | $172.92 Million USD |
| marketcap.company | $172.92 Million USD |
| Reuters | $172.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Humasis Co. Ltd
Humasis Co. Ltd. manufactures and sells pharmaceuticals and medical devices in South Korea and internationally. It offers immunodiagnostic kits, such as quantitative and qualitative tests, cardiac and cancer markers, infectious diseases, hormones, and women's health. The company also provides bio-material products, such as COVID-19 nucleocapsid protein, human immunodeficiency virus surface protei… Read more